FORM 10-K FOR THE FISCAL YEAR ENDED APRIL 30, 2003

Company

TENAX THERAPEUTICS, INC.

Filed

July 18, 2003

Period of Report

April 30, 2003

Accession Number

0001193125-03-020991

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →